Ask Warren

Myungmoon Pharm

017180 · KOSPI · ₩017180 · 명문제약

₩1,136▼ ₩14 (1.22%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩195B₩186B₩170B₩152B₩138B
Cost of sales₩88B₩81B₩74B₩74B₩75B
Gross profit₩107B₩105B₩95B₩78B₩62B
Operating income₩6.8B₩1.9B₩964M₩6.4B−₩5.9B
Net income₩1.4B−₩3.8B−₩4.9B₩8B−₩6.8B
Net income to shareholders₩1.9B−₩3B−₩5.4B₩8B−₩6.8B

Balance sheet

20252024202320222021
Total assets₩272B₩258B₩237B₩230B₩223B
Current assets₩92B₩80B₩81B₩71B₩67B
Cash and equivalents₩5.8B₩4.4B₩8B₩4.9B₩6.8B
Total liabilities₩168B₩155B₩148B₩135B₩137B
Current liabilities₩96B₩93B₩116B₩111B₩113B
Borrowings₩47B₩87B₩89B₩81B₩82B
Total equity₩104B₩103B₩89B₩95B₩86B
Shareholders' equity₩99B₩97B₩83B₩90B₩80B

Cash flow

20252024202320222021
Cash from operations−₩1.7B−₩1.3B−₩5.2B₩5.5B₩855M
Free cash flow−₩1.7B−₩1.3B−₩5.2B₩5.5B₩855M

Consolidated where available. Amounts in won.

Also known as: Myungmoon Pharm / 명문제약 / 017180 / KRX:017180

Source: KRX statistical information